Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study.

Source:http://linkedlifedata.com/resource/pubmed/id/15150554

Br. J. Cancer 2004 Jun 1 90 11 2131-4

Download in:

View as

Triples

General Info

PMID
15150554